Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.382, 2002-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ramipril `highly cost-effective' in Sweden
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :
Access to resources
Recommend
Eprosartan cost effective for hypertension in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 521, 2007-01 ,pp. :
Bisoprolol cost-effective addition in CHF in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. :
Galantamine potentially cost saving for AD in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. :
Biphasic insulin aspart lifesaving and cost saving in Sweden
Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. :